In VitroAntiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01620-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

The Discovery and Development of Boceprevir: A Novel, First-Generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease

Journal of Clinical and Translational Hepatology
2013English

Combinations of Cyclophilin Inhibitor NIM811 With Hepatitis C Virus NS3-4A Protease or NS5B Polymerase Inhibitors Enhance Antiviral Activity and Suppress the Emergence of Resistance

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

The Protease Domain Increases the Translocation Stepping Efficiency of the Hepatitis C Virus NS3-4A Helicase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Development of Cell-Based Assays for in Vitro Characterization of Hepatitis C Virus NS3/4A Protease Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Unraveling the Structural Basis of Grazoprevir Potency Against Clinically Relevant Substitutions in Hepatitis C Virus NS3/4A Protease From Genotype 1a

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Chimeric Sindbis Viruses Dependent on the NS3 Protease of Hepatitis C Virus.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1997English

Correction: Comparative Molecular Dynamics Simulation of Hepatitis C Virus NS3/4A Protease (Genotypes 1b, 3a and 4a) Predicts Conformational Instability of the Catalytic Triad in Drug Resistant Strains

PLoS ONE
Multidisciplinary
2014English

Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy